| 69.20 Delayed Data As of Nov 16 |  -0.58 / -0.83%Today’s Change | 64.27 Today|||52-Week Range 89.54 | -3.41% Year-to-Date |
| Previous close | 69.78 |
| Today’s open | 69.45 |
| Day’s range | 68.93 - 69.70 |
| Volume | 8,059,111 |
| Average volume (3 months) | 6,551,905 |
| Market cap | $90.3B |
| Earnings growth (last year) | -64.88% |
| Earnings growth (this year) | -21.96% |
| Earnings growth (next 5 years) | -2.77% |
| Revenue growth (last year) | -13.79% |
| P/E ratio | 56.7 |
| Price/Sales | 3.62 |
| Price/Book | 4.46 |
| Today’s change | Today’s % change | |
|---|---|---|
| BIIBBiogen | +2.33 | +0.72% |
| AMGNAmgen | +1.73 | +0.90% |
| ILMNIllumina Inc | +0.42 | +0.13% |
| TLRYTilray Inc | +3.21 | +2.99% |
| Next reporting date | February 5, 2019 |
| EPS forecast (this quarter) | $1.71 |
| Annual revenue (last year) | $26.1B |
| Annual profit (last year) | $4.6B |
| Net profit margin | 17.71% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director John F. Milligan |
CFO, Principal Accounting Officer & Executive VP Robin L. Washington |
Corporate headquarters Foster City, California |
